Asia Pacific Biologics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Regional

Share This On

Home > Reports > Biotechnology > Agriculture > Asia Pacific Biologics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
1. Introduction

    1.1 Executive Summary

    1.2 Market Definition

    1.3 Scope of the Study

2. Research Methodology

    2.1 Secondary Research

    2.2 Primary Research

    2.3 Analytic Tools and Model

    2.4 Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5 Expert Validation

    2.6 Study Timeline

3. Market Analysis

    3.1 Industry Value Chain Analysis

    3.2 Porter's Five Force Analysis

            3.2.1 Bargaining Power of Buyers

            3.2.2 Bargaining Power of Suppliers

            3.2.3 Threats of Substitutes

            3.2.4 Threats of New Entrants

            3.2.5 Industry Rivalry

    3.3 PESTLE Analysis

            3.3.1 Political

            3.3.2 Economical

            3.3.3 Social

            3.3.4 Technological

            3.3.5 Legal

            3.3.6 Environmental

    3.4 SWOT Analysis

            3.4.1 Strengths

            3.4.2 Weakness

            3.4.3 Opportunities

            3.4.4 Threats

    3.5 Y-O-Y Analysis

4. Market Dynamics

    4.1. Drivers

            4.1.1. Growing demand & higher acceptability for innovative therapies

            4.1.2. Loss of patent exclusivity of the leading biologics drugs

            4.1.3. Increasing capital investment from critical players

            4.1.4. Rising prevalence of chronic diseases

    4.2. Restraints & Challenges:

            4.2.1. Stringent regulatory process & Initial high capital investment

            4.2.2. Rising control & cost for accessing biologics

    4.3. Opportunities

            4.3.1. Technology advancements & drug innovations

5. APAC Biologics Market - By Product

    5.1. Introduction

    5.2. Monoclonal Antibodies

    5.3. Vaccines

    5.4. Recombinant harmonies/proteins

    5.5. Cell Therapy

    5.6. Gene Therapy

    5.7. Others

6. APAC Biologics Market – By Applications

    6.1. Introduction

    6.2. Cancer

    6.3. Infectious Diseases

    6.4. Rare Diseases

    6.5. Autoimmune Diseases

    6.6. Others

7. APAC Biologics Market - By Geography

    7.1. Introduction

    7.2. APAC

            7.2.1. China

            7.2.2. Japan

            7.2.3. India

            7.2.4. Australia & New Zealand

            7.2.3. Rest of APAC

8. Company Profiles

    8.1. AbbVie Inc.

            8.1.1. Company Overview

            8.1.2. Business Segments

            8.1.3. Financials (Public Companies)

            8.1.4. Developments

            8.1.5. SWOT Analysis (Public Companies)

    8.2. Prana Biotechnologies

    8.3. BTG PLC

    8.4. Merck & Co

    8.5. Novo Nordisk

    8.6. Lonza Group

    8.7. BioMarin Pharmaceutical

    8.8. Pfizer Inc.

    8.9. Astellas Pharma Inc.

    8.10. Johnson & Johnson

    8.11. Allergan plc

    8.12. MJ Biopharm Pvt. Ltd.

    8.13. AGC Biologics

9. Competitive Landscape

    9.1. Market Share Analysis

    9.2. Strategies Adopted by top companies

    9.3. Mergers, Acquisitions, Collaborations & Agreements

10. Market Insights

    10.1. Industry Experts Insights

    10.2. Analysts Opinions

    10.3. Investment Opportunities

11. Appendix

    11.1 List of Tables

    11.2 List of Figures

 

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion